☰

Erik Roberson

Affiliations: 
Neurology & Neurobiology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Neurodegenerative Disease
Website:
http://labs.uab.edu/erobers
Google:
"Erik Roberson"
Mean distance: 13.2 (cluster 6)
 		SNBCP
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
J. David Sweatt grad student 1991-1997 Baylor
Bruce L. Miller post-doc 2003-2005 UCSF
Lennart Mucke research scientist 2003-2006 Gladstone Institute
David G. Standaert research scientist 2008-2012 UAB

Children

Sign in to add trainee
Rachael Vollmer research assistant 2018- UAB
Samantha J Thompson research assistant 2015-2018 UAB
Yuliya Voskobiynyk grad student 2015- UAB
Jonathan R. Roth grad student 2017- UAB
Hunter Byron Dean grad student 2018- UAB
Shreya Natesh Kashyap grad student 2018- UAB
Zhiyong Li grad student 2009-2014 UAB
Brian A. Warmus grad student 2010-2014 UAB
Alicia M. Hall grad student 2009-2015 UAB
Nick Cochran grad student 2011-2015 UAB
Anthony J. Filiano post-doc 2009-2013 UAB
Travis Rush post-doc 2014-2017 UAB
Andrew E. Arrant post-doc 2013-2019 UAB

Collaborators

Sign in to add collaborator
Yuhua Song collaborator 2018- UAB (Computational Biology Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Voskobiynyk Y, Roth JR, Cochran JN, et al. (2020) Alzheimer's disease risk gene induces Tau-dependent network hyperexcitability. Elife. 9
Cochran JN, Geier EG, Bonham LW, et al. (2020) Non-Coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases. American Journal of Human Genetics
Zhang F, Gannon M, Chen Y, et al. (2020) β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade. Science Translational Medicine. 12
Staffaroni AM, Bajorek L, Casaletto KB, et al. (2020) Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 11-21
Casaletto KB, Staffaroni AM, Wolf A, et al. (2020) Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 91-105
Heuer HW, Wang P, Rascovsky K, et al. (2020) Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 60-70
Miyagawa T, Brushaber D, Syrjanen J, et al. (2020) Utility of the global CDR plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 106-117
Ramos EM, Dokuru DR, Van Berlo V, et al. (2020) Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 118-130
Narasimhan S, Changolkar L, Riddle DM, et al. (2020) Human tau pathology transmits glial tau aggregates in the absence of neuronal tau. The Journal of Experimental Medicine. 217
Dean HB, Roberson ED, Song Y. (2019) Neurodegenerative Disease-Associated Variants in TREM2 Destabilize the Apical Ligand-Binding Region of the Immunoglobulin Domain. Frontiers in Neurology. 10: 1252
See more...